Atlas Trials

Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer

Clinical trial NCT07640932 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07640932
Sponsor
Yonsei University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Small Cell Lung
Start date
2026-06-01
Primary completion
2027-04-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.